Director, US Market Access - New Products & Launch Planning

Kite Pharma•Parsippany, NJ
•$205,615 - $292,710•Hybrid

About The Position

The Director, New Products & Launch Planning reports to the Sr Director, Head of US Payer, Value, and Access Strategy. This portfolio-level individual contributor represents US Market Access in new product planning, pipeline strategy, and launch readiness for Kite’s future cell therapy assets. The role ensures US access considerations are incorporated early and effectively into global planning, evidence generation, launch strategy, commercialization assumptions, and cross-functional decisions. As the primary US Market Access lead for pre-launch and launch planning for longer-range horizon products, the Director partners with Global Market Access, Global Commercial, US Brand teams, HEOR, Medical Affairs, Regulatory, Legal, Compliance, Pricing & Contracting, Trade, Provider Access Marketing, Payer & Value Marketing, Field Market Access teams, Patient Services, and Portfolio & Strategic Planning. The role helps ensure each pipeline asset enters the US market with an integrated access-ready strategy that reflects payer, provider, employer, reimbursement, guideline, evidence, and stakeholder realities. This is a hybrid position requiring three days per week in one of the offices in Thousand Oaks, El Segundo, Foster City, or Parsippany. The position may be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives, paid time off, and company-sponsored medical, dental, vision, and life insurance plans.

Requirements

  • One of the following education and experience combinations: advanced scientific degree such as MD, PharmD, or PhD and 8 or more years of experience; master’s degree and 10 or more years of experience; or bachelor’s degree and 12 or more years of experience.
  • 10 or more years of relevant pharmaceutical or biotechnology experience in market access, launch planning, new product planning, payer strategy, global market access, commercial strategy, HEOR, or related roles.
  • Strong understanding of US market access, payer coverage, provider economics, reimbursement, guideline dynamics, evidence requirements, and buy-and-bill access considerations.
  • Experience working with global teams and influencing development, evidence, market research, and commercialization planning.
  • Ability to lead complex cross-functional workstreams without direct authority.
  • Strong strategic thinking and analytical skills, including identifying access risks early and translating them into practical mitigation plans.
  • Experience developing launch readiness plans, launch workstreams, executive updates, and governance processes.
  • High emotional intelligence and situational awareness, with the ability to collaborate effectively across functions and with senior leaders.
  • Strong project management skills and ability to manage multiple assets, deadlines, and stakeholders.
  • Advanced PowerPoint and Excel skills.
  • Excellent verbal and written communication skills.

Nice To Haves

  • Demonstrated experience supporting launch planning or new product planning for specialty, oncology, hematology, or cell therapy products.
  • Deep understanding of CAR T, hematology/oncology, or specialty therapy market dynamics.

Responsibilities

  • Serve as the US Market Access lead for pipeline assets and new product planning activities.
  • Represent US Market Access in global and cross-functional planning forums concerning pipeline assets, new indications, lifecycle opportunities, and future launch priorities.
  • Develop integrated US access strategies for pipeline assets, incorporating payer, provider, reimbursement, evidence, employer, policy, and market-readiness considerations.
  • Identify potential access risks and opportunities early in development and recommend mitigation strategies.
  • Ensure US Market Access perspectives are incorporated into global development plans, commercialization assumptions, evidence plans, value strategy, product positioning, and launch planning.
  • Lead Market Access launch planning for future assets and indications and ensure alignment across US Market Access functions.
  • Develop and maintain launch access workplans, milestones, readiness scorecards, and executive updates.
  • Partner with Provider Access Marketing and Payer & Value Marketing to identify launch resources, customer tools, value materials, and stakeholder education needs.
  • Partner with Pricing & Contracting and Trade to ensure launch planning reflects expected pricing, contracting, distribution, reimbursement, and operational requirements.
  • Ensure readiness plans address the first 30, 60, 90, and 180 days after approval, including payer coverage, provider readiness, field enablement, customer resources, and access operations.
  • Serve as a primary US Market Access interface to Global Market Access and applicable global asset teams.
  • Provide US access input into global launch planning, market research, evidence generation, payer research, value proposition development, and commercialization strategy.
  • Partner with Global and US teams to ground launch assumptions in US payer, provider, employer, reimbursement, and access dynamics.
  • Influence cross-functional teams to prioritize access-related activities critical to launch success.
  • Keep US Market Access leadership informed of key pipeline decisions, launch tradeoffs, risks, and resource needs.
  • Partner with HEOR, Medical Affairs, Regulatory, Global Market Access, and Payer & Value Marketing to identify payer and provider evidence needs for pipeline assets.
  • Identify evidence gaps that could limit coverage, reimbursement, guideline inclusion, provider adoption, or stakeholder confidence at launch.
  • Support development of payer evidence requirements, value narrative considerations, and launch-related evidence translation priorities.
  • Partner with internal teams to incorporate Market Access perspectives into NCCN and guideline planning discussions where appropriate.
  • Ensure launch planning reflects the expected evidence package, competitive profile, indication, patient population, and access-relevant clinical considerations.
  • Develop integrated launch access blueprints for pipeline assets and launch opportunities.
  • Establish governance routines and cross-functional workstreams to ensure Market Access launch readiness.
  • Partner with Portfolio & Strategic Planning to incorporate new product and launch priorities into broader US Market Access planning.
  • Provide decision-oriented updates to US Market Access Leadership and cross-functional senior leaders.
  • Create executive-level materials communicating launch risks, access assumptions, resource needs, and recommended actions.
  • Model inclusive leadership, foster belonging, coach and develop talent, align teams to organizational priorities, remove barriers, and encourage accountability.

Benefits

  • Potential eligibility for a discretionary annual bonus.
  • Potential eligibility for discretionary stock-based long-term incentives; eligibility may vary by role.
  • Paid time off.
  • Company-sponsored medical insurance.
  • Company-sponsored dental insurance.
  • Company-sponsored vision insurance.
  • Company-sponsored life insurance.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service